Eupraxia Pharmaceuticals Inc. EPRX.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · eupraxiapharma.com
Eupraxia Pharmaceuticals Inc. is a Canadian clinical-stage biotechnology company focused on developing locally delivered, extended-release drug products for therapeutic areas with high unmet medical need. The company's proprietary Diffusphere technology platform enables development of extended-release formulations designed for localized drug delivery, reducing systemic side effects.
Key ratios
ReturnOnAssets TTM -0.4
ReturnOnAssets 2025 -0.4
ReturnOnAssets 2024 -0.61
ReturnOnAssets 2023 -0.88
ReturnOnEquity TTM -0.69
ReturnOnEquity 2025 -0.69
ReturnOnEquity 2024 -1.57
ReturnOnEquity 2023 -7.15
Recent news
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
2026-06-19 · GlobeNewswire